Teva outbids Endo to secure $144m NuPathe takeover
Teva Pharmaceutical Industries has agreed to acquire NuPathe for $144m (€106m) and gain access to the company’s transdermal patch.
Archives for January 22, 2014
500 jobs to go as Novartis plans to shutter NY Diovan facility
Novartis says it intends to shutter a New York manufacturing site due to reduced demand following the loss of exclusivity on its one-time topseller Diovan.
Novo Nordisk partners e-recruitment firm to boost diabetes trial numbers
Novo Nordisk has selected patient recruitment firm Trialbee to boost participant numbers in diabetes studies using its web-based platform.
New Indian compensation formula does little to clarify situation
The new formula Indian regulators will use to calculate compensation for the families of patients who die in trials is confusing, imprecise and needs clarification, according to Outsourcing-pharma.com’s Zachary Brennan.
Quintiles says size matters when it comes to strategic deals
CEO Tom Pike emphasised Quintiles’ credentials as a Big Pharma collaborator and highlighted personalised medicines as a key driver for the CRO at an investment conference last week.
Lilly backs track-and-trace and commits $102m to fight counterfeits
Eli Lilly is spending €75m ($102m) to meet latest global anti-counterfeiting regulations, its security experts said in an exclusive interview with in-Pharmatechnologist.com.